[1]
“Prediction of Sentinel Node Positivity Risk in Melanoma Patients: When Appropriate Statistical Methodology was Employed an i31-GEP Test Did Not Outperform a Tool that Uses Clinicopathologic Features Only”, J of Skin, vol. 7, no. 6, pp. 1126–1130, Nov. 2023, doi: 10.25251/skin.7.6.7.